Jaw-in-a-Day (JIAD) 手术旨在通过单阶段颌面重建方法实现即时功能性咬合。尽管 JIAD 自 Levine 及其同事创立以来已广受欢迎，但功效和结果数据仍然有限。在本报告中，我们讨论了我们在澳大利亚三级转诊中心使用 JIAD 技术的经验。对 2022 年 4 月至 2023 年 12 月期间执行的所有 JIAD 程序进行了回顾性审查。审查的临床病理数据包括人口统计信息、初步诊断、疾病的解剖部位和术前放疗史。感兴趣的结果指标包括手术时间、植入的种植体数量、术后并发症和种植体存活率。本研究确定了 19 名患者。进行了 2 例上颌和 17 例下颌 JIAD 手术。最常见的适应症是鳞状细胞癌（n = 8）和成釉细胞瘤（n = 5）。手术并发症包括受区伤口感染（n = 3）、皮瓣裂开（n = 2）、血肿形成（n = 1）以及与部分皮瓣失败相关的颈部脓肿（n = 1）。未发现皮瓣完全失效。在总共植入的 55 个种植体中，有 1 个种植体在术后 2 个月发生失败。没有观察到受辐射植入物的损失（n = 21）。辅助放疗的中位时间为 57 天（范围：32-61 天）。 19 名患者中的 18 名 (95%) 立即实现了牙齿康复，15/19 名患者 (79%) 在随访期结束时保留了功能性修复体。我们的系列支持良性和非修复性单阶段重建的可行性恶性指征。需要进一步的研究来了解 JIAD 技术的长期功能、美学和健康相关的生活质量结果。© 2024 作者。约翰·威利 (John Wiley) 出版的 ANZ 外科杂志

The Jaw-in-a-Day (JIAD) procedure aims to achieve immediate functional occlusion via a single-stage approach to maxillofacial reconstruction. While JIAD has gained popularity since its inception by Levine and colleagues, efficacy and outcome data remain limited. In this report, we discuss our experience with the JIAD technique at an Australian tertiary referral centre.A retrospective review of all JIAD procedures performed from April 2022 to December 2023 was conducted. Clinicopathologic data reviewed included demographic information, primary diagnosis, anatomical site of disease, and history of pre-operative radiotherapy. Outcome measures of interest included operative time, number of implants placed, post-operative complications and implant survival.Nineteen patients were identified for the study. Two maxillary and 17 mandibular JIAD procedures were performed. The most common indications were squamous cell carcinoma (n = 8) and ameloblastoma (n = 5). Surgical complications included recipient site wound infection (n = 3), flap dehiscence (n = 2), haematoma formation (n = 1), and neck abscess associated with partial flap failure (n = 1). No total flap failures were identified. Of the 55 total implants placed, one implant failure occurred 2-months post-operatively. No loss of irradiated implants (n = 21) was observed. The median time to adjuvant radiotherapy was 57 days (range, 32-61). Eighteen of 19 patients (95%) achieved immediate dental rehabilitation, and 15/19 patients (79%) retained a functional prosthesis by the end of the follow-up period.Our series supports the feasibility of single-stage reconstruction for both benign and malignant indications. Further research is required to understand the long-term functional, aesthetic, and health-related quality-of-life outcomes with the JIAD technique.© 2024 The Author(s). ANZ Journal of Surgery published by John Wiley & Sons Australia, Ltd on behalf of Royal Australasian College of Surgeons.